Weak Recommendation to Screen for Bacteriuria in Pregnancy

Share this content:
Weak Recommendation to Screen for Bacteriuria in Pregnancy
Weak Recommendation to Screen for Bacteriuria in Pregnancy

TUESDAY, July 31, 2018 (HealthDay News) -- Very low-quality evidence supports screening for elevated bacteria levels in urine during the first trimester for non-symptomatic pregnant women, according to a clinical guideline published in the July 9 issue of CMAJ, the journal of the Canadian Medical Association.

Ainsley Moore, M.D., and colleagues from the Canadian Task Force on Preventive Health Care, conducted a systematic review and engaged 34 women who were either pregnant or of childbearing age to guide the development of the updated recommendations.

The Task Force gives a weak recommendation in favor of screening pregnant women for asymptomatic bacteriuria with urine culture once during the first trimester. The Task Force found scant and very low-quality evidence regarding harms associated with screening and treatment of asymptomatic bacteriuria in pregnancy. They discovered patient values and preferences regarding screening varied and were influenced by individual perspectives regarding the small potential benefit of antibiotic use as well as potential harms associated with antibiotic use in pregnancy. Women at increased risk of urinary tract infections in pregnancy should follow guidance for populations at higher risk.

"It ultimately comes down to patient preferences and a discussion between the clinician and patient to determine these [screening preferences]," Brett Thombs, Ph.D., chair of the Task Force, said in a statement.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »